Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...
Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback